Rosiglitazone effect on PRDM16-deficient inguinal white adipose tissue: stromal-vascular cells - - GEO DataSets - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

Result Filters

Summary

Format

Summary
Summary (text)
Unique Identifier List

Send to:

Choose Destination

File
Clipboard
Collections

Links from GEO Profiles

Full record GDS4021

Rosiglitazone effect on PRDM16-deficient inguinal white adipose tissue: stromal-vascular cells

Analysis of SV cells isolated from PRDM16-depleted inguinal white adipose tissue (WAT) treated with rosiglitazone. Antidiabetic PPARγ ligand drugs, such as rosiglitazone, activate a browning of WAT. Results provide insight into molecular mechanisms underlying white-to-brown fat conversion.

Organism:: Mus musculus

Type:: Expression profiling by array, count, 2 agent, 2 genotype/variation sets

Platform:: GPL8321
Series:: GSE35011
8 Samples

Download data: CEL

DataSet

Accession:: GDS4021

ID:: 4021

PubMed Full text in PMC Similar studies GEO Profiles Analyze DataSet

Supplemental Content

Related information

PubMed
Related PubMed entries
Full text in PMC
PMC links
Similar studies
Similar studies
GEO Profiles
Related GEO
BioProject
BioProject links
GEO DataSets
Related GEO DataSets
Taxonomy
Taxonomy

Important Links

Recent activity

Clear Turn Off Turn On

Related DataSets for GEO Profiles (Select 76227578) (1)
GEO DataSets
Rosiglitazone effect on PRDM16-deficient inguinal white adipose tissue: stromal-...
Rosiglitazone effect on PRDM16-deficient inguinal white adipose tissue: stromal-vascular cells
Accession: GDS4021

GEO DataSets

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

You are here: NCBI > Genes & Expression > Gene Expression Omnibus (GEO) Datasets